Pittsburgh approach has lung transplant patients taking fewer drugs

Surgeons at the University of Pittsburgh Medical Center (UPMC) have instituted a new clinical protocol that has the potential to redefine the standard of care for lung transplant patients. Bucking conventional thought that successful lung transplantation can only be achieved with a three-punch assault on the immune system, the new protocol is a departure from the triple-drug therapy in place at nearly every other transplant center.